Tropomodulin is a 40.6-kD protein that colocalizes with actin filament pointed ends in skeletal muscle. We report the sequence of two partial-length complementary DNA (cDNA) clones of rat cardiac tropomodulin that cover 90% of the coding region. The cDNA sequence is 90% conserved between human and rat, with the predicted amino acid sequence similarity even higher at 95%. Anti-tropomodulin antibodies label a single polypeptide with an apparent mobility of 43 000 in Western blot analysis of rat cardiac muscle. Immunofluorescence experiments using this anti-tropomodulin antibody result in labeling that is coincident with thin filament ends, as demonstrated by double localization with a-actinin antibody. Tropomodulin protein is organized into a sarcomeric staining pattern with the earliest appearance of myofibrils in rat cardiocytes. The localization of tropomodulin protein at or near thin filament ends led us to examine the distribution of tropomodulin messenger RNA (mRNA) during myofibrillar development in vitro. Fluorescent in situ hybridization experiments using tropomodulin cDNA probe in cardiocytes that have been cultured for 3 to 5 days show a distribution of large mRNA patches. The cytoplasmic location of tropomodulin mRNA at this time, which bears no relation to the developed myofibrils, suggests that tropomodulin protein is targeted to thin filament ends rather than using localized translational machinery. However, the distribution of tropomodulin mRNA in cultured cardiocytes changes over the next 2 weeks from large perinuclear patches to small concentrations arranged along myofibrils throughout the cell. The reorganization of tropomodulin mRNA throughout the cardiocyte appears to be distinct from the pattern of glyceraldehyde-3-phosphate dehydrogenase mRNA within the same time period. Increasing intracellular density of myofibrils within developing cardiocytes may lead to redistribution of selected mRNAs for localized translation. (Circ Res. 1994;75:221-232.) Key Words * tropomodulin * myofibrils * mRNA localization * cardiac muscle, rat M yofibrillar organization has been extensively characterized, particularly with respect to the relation of thick and thin filaments during myofibrillogenesis (for a review, see Reference 1). The incorporation of thin filaments into muscle fibrils appears to progress from formation of stress fiber-like structures to nonstriated myofibrils and, finally, to striated myofibrils.2 Nonstriated myofibrils contain all the constituent proteins of thin filament complexes in unorganized aggregates. The presence of ectopic I-Z-Ilike structures outside the nonstriated myofibrils during myofibrillogenesis indicates that thin filament structures can form without cues from thick (myosin) filaments.
Tropomodulin in Rat Cardiac Muscle
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Accurate control of thin filament length is critical for sarcomeric function. Nebulin is hypothesized to be a molecular template for thin filament polymerization and length regulation in skeletal muscle based on the ability of nebulin fragments to bind actin filaments3 and a strong correlation between nebulin size and thin filament length in a variety of muscle types.4,5 Thin filament growth from the fast-growing (barbed) end is prevented by Cap Z, an actin-binding protein located at the Z-disc.67 However, a comparable protein that inhibits thin filament growth from the slow-growing (pointed) end at the periphery of I-Z-I brushes has not been identified. Nebulin is not involved in this process directly, since there is no evidence that nebulin can inhibit the growth of actin filaments. Furthermore, nebulin is absent from cardiac muscle, where, despite increased variation in thin filament length, thin filaments are still organized into well-defined I-Z-I complexes. 8 Recently, a tropomyosin-binding protein, called tropomodulin, was identified at the pointed ends of thin filaments in rat skeletal muscle. 9 Tropomodulin is the first protein to be associated solely at or near thin filament pointed ends. Skeletal muscle tropomodulin is present in stoichiometric ratios with actin filaments at 1.2 to 1.6 molecules per filament. Also, tropomodulin association with thin filaments is not dependent on the presence of thick filaments. Thus, tropomodulin is present in the proper location and amount to play a role in regulating skeletal muscle thin filament length. We have cloned and immunolocalized rat cardiac tropomodulin and report our findings in relation to previously characterized tropomodulin.
Tropomodulin has been suggested to function in the regulation of thin filament length by binding to tropomyosin and preventing tropomyosin-mediated stabiliza-tion of the actin filament.10 Tropomodulin was originally identified as a protein component of the human erythrocyte membrane cytoskeleton with a molecular weight of 43 000.1" The full-length complementary DNA (cDNA) sequence of human fetal liver tropomodulin codes for a 40.6-kD product that shares no significant homology with any other proteins. 12 Tropomodulin has now been identified in various tissues including muscle, lens of the eye, and brain.13 '14 In each case, tropomodulin is associated with postmitotic cells at late stages of terminal differentiation. Preliminary results suggest that binding of tropomodulin to thin filaments is delayed until after striated myofibrils have formed.15 Because tropomodulin is a tropomyosin-binding protein that releases erythrocyte tropomyosin from actin filaments,10 we were interested in the process by which tropomodulin becomes specifically localized at or near thin filament ends without disturbing previously associated tropomyosin molecules. Reports of localized messenger RNA (mRNA) translation or cotranslational assembly in muscle cells or tissues led us to examine the distribution of tropomodulin mRNA during cardiocyte differentiation by in situ hybridization. We discuss our findings for tropomodulin mRNA localization in comparison with the distribution of other muscle mRNAs and propose a mechanism to account for tropomodulin assembly onto organized thin filament structures.
Materials and Methods

Cloning and Sequencing of Rat Cardiocyte Tropomodulin cDNAs
A recombinant Agtll phage library containing cDNA inserts of rat cardiac poly A+ selected mRNA (Clontech) was screened using a partial-length cDNA clone of human fetal liver tropomodulin (clone 10 as described in Reference 12; kindly provided by L.A. Sung). Two rounds of Southern blot screening were performed as previously described,'6 followed by immunoscreening of selected clones with anti-tropomodulin antibody and detection using alkaline phosphotase following standard procedures. Reactive clones identified by both Southern and Western blotting assays were amplified; the tropomodulin insert was excised by restriction digest and subcloned into the Bluescript SK 11+ plasmid (Stratagene) for sequencing. Tropomodulin cDNAs were sequenced by primer extension reactions using the Sequenase V2.0 kit as directed by the manufacturer (United States Biochemicals). Sequences for the tropomodulin cDNAs were verified for accuracy by automated DNA sequencing provided by the University of Southern California DNA sequencing core facility in Dr Minnie McMillan's laboratory (Bill Schulz, technician).
Western Blot Analysis
Rat cardiocytes isolated as previously described'7 were plated onto 100-mm plastic Petri dishes coated with laminin (Sigma Chemical Co; catalog no. L 2020; diluted in phosphatebuffered saline [PBS] and used at a concentration of 50 ,ug/mL). Cells that had been cultured for at least 4 days were washed twice with PBS and solubilized in sodium dodecyl sulfate (SDS) sample buffer containing 8 mol/L urea. After sonication to shear chromosomal DNA, the samples were placed in boiling water for 5 minutes, cooled to room temperature, and electrophoresed on a 10% polyacrylamide SDS gel as previously described.'8 The separated rat cardiocyte proteins were transferred to nitrocellulose as previously de- scribed,19 and the blot was heated at 60°C for 1 hour to decrease loss of tropomodulin protein from the blot during subsequent immunoblotting procedures." Anti-tropomodulin antibody generated in rabbits against purified human erythro-cyte tropomodulin'0 and preadsorbed on a rabbit troponin I affinity column was used at a concentration of 4 ,ug/mL as previously described20 in overnight incubation. Bound antibody was detected using a horseradish peroxidase-conjugated anti-rabbit secondary antibody followed by enhanced chemiluminescence reaction as directed by the manufacturer (all purchased from Amersham Life Sciences). Kodak X-Omat AR film was exposed to the blot for 10 to 30 seconds.
Immunofluorescence Localization
Rat cardiocytes were isolated from 2 to 3-day-old pups as previously described.17 Cells were plated onto laminin-coated glass coverslips (as described for Western blot analysis; see above) and cultured for 3 to 4 days in minimum essential medium without L-glutamine containing 2% fetal bovine serum and 1% penicillin/streptomycin (GIBCO Laboratories).
Cells were prepared for immunofluorescence using standard procedures as previously described.20 Polyclonal anti-tropomodulin antibody was produced in rabbits, affinity-purified and preadsorbed as previously described (Reference 10; see Western blot protocol), and used at a concentration of 5 ,ug/mL. Monoclonal a-actinin antibody from mouse (Sigma catalog no. A 7811; produced against rabbit skeletal muscle a-actinin) was used at 1:250 dilution. Secondary fluoresceinconjugated anti-rabbit IgG antibody or rhodamine-conjugated anti-mouse IgG (both from Boeringer-Mannheim Biochemicals) was used at 1:250 dilution. Immunostained cardiocytes were mounted in Vectashield antibleaching medium (Vector Laboratories) and viewed using a Zeiss LSM-1 laser scanning confocal microscope equipped with filters for fluorescein and rhodamine epifluorescence (operated by the Doheny Eye Institute; Dr Janet Blanks, director). Planneofluor x40 (N.A., 0.75) and x63 (N.A., 1.40) oil immersion objectives were used for imaging of fluorescently labeled cells. Image analysis was performed using the standard system operating software provided with the Zeiss LSM microscope (Version 2.08). Photomicrographs were taken using a Sony printer connected to the video output of the microscope.
Fluorescent In Situ Hybridization
Rat cardiocytes were isolated from 2to 3-day-old pups as previously described.17 Cells were plated onto glass coverslips coated with laminin as described for immunofluorescence experiments (see above). Tropomodulin probe was prepared from the rat cardiocyte cDNA clone B2, a 538-bp fragment that covers the 3' terminal region of tropomodulin (nucleotides 457 through 995 shown in Fig 1) . Glyceraldehyde-3phosphate dehydrogenase (GAP-DH) probe was excised from a previously cloned cDNA probe.2' The irrelevant DNA control probe was a 1.167-kb fragment of bacterial plasmid cloning vector (pCR II vector; InVitrogen) linearized by Pvu I digest and purified by agarose gel electrophoresis. Probe DNA was labeled using a photoactivatable form of biotin as directed by the manufacturer (Photoprobe Biotin; Vector Laboratories). Four to 10 coverslip samples from previously prepared cardiocyte preparations were removed from the freezer and placed in a sealed box containing CaSO4 (drierite dehydrant) for 30 minutes to defrost. Cardiocytes were fixed in 4% paraformaldehyde solution for 20 minutes at room temperature followed by three washes with PBS for 10 minutes each. Coverslips were then rinsed in 0.1 mol/L triethanolamine pH 8.0 for 1 minute to quench the paraformaldehyde, followed by another 10-minute wash in PBS. The cells were then permeabilized in 100% methanol for 5 minutes at -20°C and washed again twice in PBS at room temperature for 10 minutes each. The coverslips were then rinsed in diethyl-pyro-carbonatetreated (RNAse-free) water for 1 minute. After this, cells were dehydrated in a series of eight ethanol baths in concentrations of 30%, 50%, 70%, 85%, 95%, 95%, 100%, and 100% again for 3 minutes in each bath. The dehydrated slips were then placed on the counter to dry. Prehybridization buffer (not Nucleotide Sequences of Rat and Human Tropomodulin cDNA Clones containing probe) was applied to each individual coverslip, followed by incubation in a humid chamber at 37°C for 2 to 3 hours. The buffer used for prehybridization and subsequent hybridization steps consisted of 50% formamide, 4x standard saline citrate, 5 x Denhardt's reagent, 1% SDS, 10% dextran sulfate, 2 ,ug/mL salmon sperm DNA, and 0.1 mol/L dithiothreitol.22 After prehybridization, the coverslips were hybridized by addition of the biotinylated probe at a concentration of 4.5 ,ug/mL overnight at 37C. The next day, coverslip samples were washed in 4x SSC solution for 25 minutes at room temperature, followed by washes at 37°C in 2x SSC solution for 2 hours and 0.5 x SSC solution for 30 minutes. Then coverslips were washed twice in PBS containing 1% Triton X-100 (PTX) solution for 5 minutes each at 45°C. After PTX washes, the coverslips were placed faceup on a flat surface and flooded with diluted rhodamineavidin (Vector Laboratories) solution. Rhodamine-avidin was prepared by microcentrifugation for 5 minutes and then dilution with PBS containing 20% horse serum (PBS-HS) to a final concentration of 1:80. Coverslips were incubated in the dark with rhodamine-avidin at 37°C for 20 minutes and then washed twice in PTX solution for 3 minutes each. Biotinylated anti-avidin D (BAAD, Vector Laboratories) was diluted in PBS-HS to a final concentration of 1:100. Diluted BAAD was added to the coverslip samples, which were incubated in the dark for 20 minutes and then received two washes in PTX for 3 minutes each. Diluted rhodamine-avidin and BAAD solutions were added alternately to the coverslips again, being rinsed by two 3-minute washes of PTX between incubations. After the last rhodamine-avidin incubation, coverslips received two more washes of PTX solution and three washes of 1 x PBS, and, finally, the coverslips were mounted (Vectashield Fluorescence Medium, Vector Laboratories) and viewed with a Zeiss LSM-1 confocal microscope.
Results
Cloning and Sequence Analysis of Rat Cardiac Tropomodulin A partial-length cDNA clone of human fetal liver tropomodulin was used to screen approximately 106 recombinant Agtll phage of a rat cardiocyte cDNA library. Selected clones were subjected to immunoscreening with affinity-purified anti-human erythrocyte tropomodulin antibody. Two overlapping clones were isolated containing inserts of 438 base pairs (clone SK111, nucleotides 1 through 477) and 538 base pairs (clone B2, nucleotides 457 through 995). The inserts of the two isolates were subcloned into Bluescript SK± and sequenced by primer extension to verify authenticity of the clones. The two clones combined cover 90% of the coding region previously described for human fetal liver tropomodulin.12 Fig 1 shows the sequence alignment between the rat cardiocyte and human fetal liver tropomodulin cDNAs. The sequence of clone SK111 aligns with nucleotides 105 through 582 of human tropomodulin, whereas clone B2 matches nucleotides 562 through 1080, resulting in a 20-bp overlap between the two clones. Thus, our 5' clone (SK11) does not contain the first 35 codons for the tropomodulin sequence (including the initiation site), but our 3' clone (B2) contains the termination codon (TAG at nucleotides 1078 through 1080) as well as 20 base pairs of 3' untranslated sequence. The aligned 975 -bp region of rat cardiocyte tropomodulin shares a 90% similarity with the human fetal liver tropomodulin nueleotide sequence. Many of the nucleotide substitutions are degenerated third base changes that do not affect the predicted amino acid sequence of the protein. Due in part to these irrelevant base changes, 95% of the amino acid residues are identical between the rat and human tropomodulin clone-predicted amino acid sequences.
Anti-Tropomodulin Antibody Reacts With Rat Cardiocyte Tropomodulin in Western Blot Analysis
A rat cardiocyte cell lysate was prepared from cells that were cultured in vitro for 3 to 5 days. After SDS-gel electrophoresis and transfer to nitrocellulose, a Western blot was performed to determine the reactivity of anti-tropomodulin antibody with cardiocyte proteins. Fig 2 shows that anti-tropomodulin antibody reacts with a polypeptide with an apparent mobility of 43 000, consistent with the apparent size of tropomodulin on SDS gels.' l Fowler'0 noted immunological cross-reactivity of anti-tropomodulin antibody with troponin I from rat and rabbit striated muscle. The antibody used in this report was preadsorbed to eliminate this potential cross-reactivity (see "Materials and Methods") and does not detect any other polypeptides in Western blot analysis of rat heart. Tropomodulin Colocalizes at or Near Thin Filament Ends in Rat Cardiocyte Myofibrils Tropomodulin is located at the pointed ends of actin filaments in chicken (M.A.S., unpublished data) and rat9 skeletal muscle. The photomicrographs in Fig 3 demonstrate that tropomodulin in rat cardiocytes colocalizes in the same region as the pointed ends of thin filaments, consistent with previous immunolocalizations of tropomodulin in striated muscle. Cardiocytes were cultured in vitro for 3 to 4 days and then stained for immunofluorescence with anti-tropomodulin antibody together with anti-ca-actinin antibody (Fig 3A and 3B) . Tropomodulin and a-actinin labelings appear to be mutually exclusive, alternating between a-actinin (at Z-dises) and tropomodulin (where thin filament ends from adjacent I-Z-I brushes meet). The distance between the regularly spaced intervals of tropomodulin MX1 0-3 1'A BF 3), in agreement with previous observations of actin filament length in rat cardiac muscle.8 Adjacent a-actinin bands are also approximately 2.0 gm apart, indicating that the myofibrils are in a contracted state. This contracted condition accounts for the tropomodulin bands appearing as a single line rather than a doublet, as has been previously observed in skeletal muscle (Reference 9 and M.A.S., unpublished data).
Tropomodulin mRNA Changes as Rat Cardiocytes Develop In Vitro
Tropomodulin protein association with the region where actin filaments terminate in myofibrils could depend on either specific targeting signals encoded within the molecule or localized translation of tropomodulin mRNA where the protein is concentrated along the myofibril. In situ hybridization was performed using cardiocytes grown in vitro to observe the distribution of tropomodulin mRNA relative to protein localization in myofibrils. Bands of localized tropomodulin protein appear within 2 to 3 days after cardiocyte isolation at the onset of cardiocyte contractility in culture (see Fig 3) . Thus, for initial in situ hybridization experiments, cardiocytes were cultured for 5 days to allow time for development of extensive myofibrillar organization. Tropomodulin mRNA was detected using a biotinylated tropomodulin cDNA fragment with subsequent labeling of biotin with fluorescent conjugated avidin. These experiments show a perinuclear distribution of tropomodulin mRNA (Fig 4A and 4B ) that bears no resemblance to the extensive ordered myofibrillar architecture found in cardiocytes before this time ( Fig  3) . Parallel experiments performed on cells from the localization measures approximately 2.0 gm across (Fig same preparation using biotinylated DNA with irrele-vant nucleotide sequence confirm the specificity of our tropomodulin probe, with faint nonspecific labeling of the cardiocytes (Fig 4C and 4D) . These results indicate that the distribution of tropomodulin protein in cardiocytes during myofibril formation is not dependent on localized production of tropomodulin near thin filament ends.
Skeletal or cardiac muscle cells allowed to differentiate in vitro over a period of days to weeks continue to synthesize myofilament proteins and assemble myofilament structures. In addition, the intracellular organization of the cells becomes more refined as myofilaments align relative to each other in densely packed networks. Cardiocytes at various times after in vitro culture are compared in Fig 5 to observe tropomodulin mRNA distribution in tandem with ongoing differentiation. Recently isolated cells after 3 days in culture show tropomodulin mRNA present in a patchy pattern throughout the cell body ( Fig 5A and SB) , unrelated to the distinct patterns observed for the myofibrillar proteins. These mRNA patches at 3 days are more dispersed throughout the cytoplasm than those observed in the cardiocytes cultured for 5 days (Fig 4) .
Changes in distribution of tropomodulin mRNA become apparent when cells are allowed to differentiate over 3 weeks in vitro. After 10 days in vitro, the large patches of tropomodulin mRNA patches seen at 3 days ( Fig 5A and SB) disappear throughout most of the cytoplasm, although tropomodulin mRNA still appears to be concentrated around the two nuclei (Fig SC and  SD) . These large perinuclear patches of tropomodulin mRNA eventually give way to a widespread distribution of small mRNA concentrations, which follow the contours of the myofilaments within cardiocytes maintained in vitro for 3 weeks (Fig SE and SF) . In some areas, the distance between clusters of tropomodulin mRNA was measured as approximately 2.0 gm (Fig SF, arrows) . This distance is consistent with previously observed measurements of tropomodulin localization along myofilaments ( Fig 3B) . Myofibrillar organization was observed within all cardiocytes at the various time points tested using phalloidin to show actin filaments (example of 10-day cells shown in Fig SG) . Control cells subjected to the hybridization protocol without the addition of tropomodulin probe lack specific labeling (example of 10-day cells shown in Fig SH) , appearing to be comparable to previous controls performed using an irrelevant cDNA probe (Fig 4C and 4D) .
GAP-DH mRNA Distribution Differs From That of Tropomodulin
The pattern of tropomodulin mRNA in cultured rat cardiocytes shows a distribution that progresses from diffuse patches to perinuclear accumulations and, finally, a fine fibrillar pattern. Because tropomodulin mRNA localization appears generally to be unrelated to sarcomeric organization in these cultured cells, we were interested in whether distribution of tropomodulin mRNA in cardiocytes was comparable to that of an unrelated nonsarcomeric mRNA. Additional in situ hybridization experiments were performed using a biotinylated cDNA probe for GAP-DH, a metabolic enzyme that is constitutively expressed in high levels in striated muscle.2' Results of these experiments show that after 10 days in vitro, GAP-DH mRNA is distrib-uted as punctate dots throughout the cytoplasm of the cell with a gradient of intensity leading away from the nucleus (Fig 6C) . This localization is in contrast to the large patches of tropomodulin mRNA that are present in the perinuclear region at this same time (see Fig 5C  and 5D ). This difference becomes less pronounced by 21 days (Fig 6D) , when patterns of both tropomodulin and GAP-DH are distributed throughout the cells. However, the pattern of tropomodulin mRNA at 21 days is fibrillar, whereas the GAP-DH label is diffuse and uniform. The distribution of both mRNAs in cells cultured for 3 days appears to be comparable (Fig SA and SB for tropomodulin; data not shown for GAP-DH). We have repeated this experiment several times using both the GAP-DH and tropomodulin probes with cardiocytes from the same preparation and find that the distinct distributions of the two mRNAs as described here are observed consistently. Thus, a differential intracellular mRNA redistribution occurs between tropomodulin and GAP-DH mRNAs during the course of cardiocyte differentiation in vitro.
Discussion
Three main categories of filament proteins are involved in myofibrillar organization: myosin (thick filaments), actin (thin filaments), and titin (gap filaments). All three filament types are woven together in an assembly cascade that depends on a highly regulated sequence of temporally and spatially coordinated events. The developmental expressions of titin and myosin are tightly linked, and thick filament organization leading to sarcomeric periodicity can proceed in the absence of any thin filaments. 23 The specific cues that initiate the ultimate organization of striated myofibrils and integration of thin filaments are still unknown. Identification of the proteins involved in this process and determination of the mechanisms of their association have led to our current understanding of myofibrillogenesis. Tropomodulin is a newly characterized component of myofibrillar organization, and the results presented in this report provide new information about the role of tropomodulin in cardiac development.
The rat cardiac tropomodulin cDNA sequence reported here is highly related to the human fetal liver tropomodulin cDNA reported by Sung et al.12 Three tropomodulin mRNAs have been identified in human heart that are expressed at high levels (and possibly a fourth at low level), all of which appear to have identical coding regions with varying lengths of untranslated sequences.12'24 Our Northern blot analysis of rat heart tissue14 indicates that two major and one minor tropomodulin transcripts are detected with tropomodulin riboprobe (synthesized from clone B2) corresponding to 5.0, 2.6, and 3.2 kb, respectively. Our data as well as those of Sung et al12 suggest that all of the coding regions of these various sized transcripts are identical. Northern blot analyses of human reticulocyte RNA show two transcripts that contain identical coding regions with differences in size due to the length of untranslated regions.12 Furthermore, substantial conservation between rat and human tropomodulin coding regions might be expected considering that all murine tropomodulin transcripts originate from a single gene that is not alternatively spliced (M. Ito, B. Swanson, M.A. Sussman, G. Lyons, and L. Kedes, unpublished Photomicrographs of confocal immunofluorescence localization of tropomodulin in rat cardiocytes. Cells were isolated as described in -Materials and Methods-and cultured in vitro for 3 days before immunolabeling as follows: A and B, double labeling with antibody to tropomodulin (green) and a-actinin (red) at low (A) and high (B) magnification. Note that reactivity with cv-actinin (at Z-discs) is clearly separated from the tropomodulin label, which colocalizes with the region where actin filaments end. The distance between neighboring a-actinin bands is approximately 2.0 gm, consistent with expectations for a contracted myofibril. The tropomodulin label appears as a single band due to the contracted state of the myofibrils. The measurement bars shown are 10 gm in A and 5 gm in B. FIG 5. Photomicrographs of fluorescent in situ hybridization of tropomodulin messenger RNA (mRNA) in rat cardiocytes at various times after isolation. Cells were isolated and cultured in vitro for 3, 10, or 21 days before in situ hybridization with biotinylated tropomodulin complementary DNA probe. Bound probe was detected using rhodamine-avidin as described in "Materials and Methods." A and B, Pattern of mRNA distribution in cells cultured for 3 days. A widespread distribution of large mRNA patches throughout the cell cytoplasm is evident (x 11 00). C and D, Pattern of mRNA distribution in cells cultured for 10 days. Large patches of mRNA are restricted primarily to the perinuclear region with smaller concentrations distributed randomly throughout the cytoplasm (x880). E, Pattern of mRNA distribution in cells cultured 21 days. Large patches of mRNA are not observed, and small concentrations of mRNA are spread throughout the cytoplasm (x1 00). F, Striated appearance of mRNA at the periphery of a cell cultured for 21 days. Regions such as this are occasionally seen at cell edges, with a periodic distribution of mRNA measuring 2.0 gm between stripes (at arrows). G, Fluorescent image of cell cultured for 10 days and labeled with rhodamine-conjugated phalloidin to show actin filaments. Note the extensive myofibrillar network, which bears no relation to the pattern of mRNA expression (x880). H, Cell cultured for 10 days and treated as A through F except that tropomodulin complementary DNA probe was not added in the in situ hybridization step. No labeling of the cell cytoplasm is seen (x880). 2~~~~~( c: E F-data). Thus, it is likely that the probe used for the in situ hybridization experiments described here would detect all tropomodulin mRNAs. Immunofluorescence localization of tropomodulin in cultured rat cardiocytes (Fig 3) is consistent with previous findings of tropomodulin association with the pointed ends of actin filaments in skeletal muscle of rats9 and chickens (M.A.S., unpublished data). Microscopy of skeletal muscle shows that tropomodulin labeling moves with the I-Z-I brushes and can be resolved into a doublet of neighboring thin filament ends by stretching the myofibril. Separation of thin filament ends in rat cardiocytes is not far enough to resolve labeling of the two sides, since the measured distance between Z-discs of approximately 2.0 gm indicates that the myofibrils are contracted. However, the mutually exclusive alternation between a-actinin and tropomodulin label demonstrates that tropomodulin reactivity resides exclusively within the A-band of the sarcomere. Furthermore, the measured distance between tropomodulin bands of approximately 2.0 gm is consistent with expectations for I-Z-I complex width. 8 Thus, the localization of tropomodulin in rat cardiocytes agrees with our current hypothesis involving regulation of thin filament length from the pointed end. Preliminary results examining the stabilization of tropomyosin-coated actin filaments by tropomodulin in vitro also support this hypothesis. 25 For tropomodulin to be effective at thin filament length regulation, the protein must be specifically targeted to appropriate thin filament ends in the correct temporal sequence with other myofibrillar proteins. Tropomodulin has been suggested to be among the last, if not the last, protein component incorporated into organized striated myofibrils during chicken cardiocyte differentiation.15 The immunofluorescence results in this report show that tropomodulin is organized within myofibrils of rat cardiocytes as soon as contractile striated myofibrils appear (2 to 3 days after dissociation and plating). Incorporation at this time suggests that tropomodulin may be required for stabilization of thin filaments but not for I-Z-I complex assembly. Because the mechanism by which tropomodulin is targeted to actin filament ends is unknown, this study used fluorescent cDNA probes to examine how tropomodulin mRNA is organized during development of intracellular cardiocyte myofibrillar structure and whether the message is redistributed as the intracellular cardiocytes structures are allowed to mature.
Recent application of fluorescent in situ hybridization to cells and tissues has revealed that the intracellular mRNAs can be redistributed during growth and development to selected subcellular sites.2627 Results of in situ hybridization experiments have led to various theories of mRNA sorting and/or targeting such as mRNAcytoskeleton association and directed transport of selected mRNAs, perhaps leading to translation of the mRNA linked to incorporation of newly synthesized protein products (cotranslational assembly; reviewed in Reference 28). Muscle tissue would appear to be an ideal environment to assess the localization of contractile proteins relative to the sarcomeric organization of the myofibril. However, analysis of muscle tissues by fluorescent in situ hybridization has produced results supporting a variety of mRNA translational models. For example, in situ hybridization studies on myosin mRNA localization have argued both for2930 and against3' a cotranslational model of thick filament assembly. Interpretation of nebulin mRNA localization in a periodic pattern32 is unclear, since the organization of the protein product precedes localization of the mRNA by several days.
Our results demonstrate that the organization of myofibrillar structure and localization of tropomodulin protein to the pointed ends of actin filaments occur, for the most part, independent of tropomodulin mRNA location. However, we observed a clear redistribution of the tropomodulin mRNA over the 21-day period of cardiocyte cell culture in vitro (Fig 4) . We believe that the differences between the patterns of tropomodulin and GAP-DH reactivity are due to sequence specificity of the probe rather than to probe concentration or abundance of mRNA. Initial experiments to determine optimal probe concentration showed that changes in probe concentration resulted in increasing or decreasing fluorescence intensity, not changes in the observed pattern (data not shown). Changes in tropomodulin mRNA organization are most likely explained by the reformation of intracellular myofibrillar structure occurring throughout the 21-day in vitro culture period. Although contractility is lost during the initial dissociation and plating of cardiocyte cells due to the disassembly of myofibrils, intracellular structures are resynthesized and organized in the days following in vitro culture. 33 Myofibrils continue to accumulate, and contractility stimulates enhanced myofibrillar organization. Fully differentiated cardiocytes contain a densely packed network of myofibrils that occupy the majority of intracellular volume, excluding cytoplasm to intermyofibrillar spaces. Although diffusion of mRNA and/or proteins may occur with relative ease during the initial stages of myofibril synthesis (ie, 3 days after isolation), the increasing density of the myofibrillar lattice eventually restricts mRNA to a perinuclear distribution and ultimately to the cytoplasmic space between adjacent myofibrils. These changes in tropomodulin mRNA localization reported in this study are consistent with the restricted diffusional model as described by Russell and Dix.31 However, distinct distributions of tropomodulin mRNA versus GAP-DH mRNA within cardiocytes cultured for several days or more in vitro ( Fig 6) demonstrate that mRNAs may be differentially localized irrespective of sarcomeric or myofibrillar organization. Furthermore, tropomodulin mRNA is also occasionally distributed with a 2.0-gm spacing characteristic of sarcomeres in cardiocytes ( Fig  4F) , suggesting that tropomodulin mRNA may be localized relative to myofibrillar proteins in selected regions of the cell, perhaps those undergoing rapid growth or repair. At this point, more than one mechanism appears to be operating within developing cardiocytes to target tropomodulin mRNA localization, and multiple mechanisms could also account for the disparity in conclusions of localization studies examining myosin mRNA distribution.
The functional role for tropomodulin in cardiac development is the subject of ongoing experiments, along with studies in neuronal and eye lens cell development. There is scant information currently available regarding the function of tropomodulin in nonmuscle cells. Re-cent reports have demonstrated concentration of tropomodulin at neuromuscular junctions39 and in selected subsets of neuronal cells in the central nervous system.14 Tropomodulin is characteristically found in cell and tissue types containing highly specialized structures that are normally maintained intact throughout life. Interestingly, expression of tropomodulin in the central nervous system occurs developmentally together with neuronal differentiation and intense synaptogenesis.14 Current hypotheses regarding tropomodulin's ability to determine and/or stabilize actin filament length at the pointed end are based on circumstantial localization evidence together with biochemical data regarding the interaction of tropomodulin with tropomyosin and tropomyosin/actin filaments.9'1034 In addition, experiments in progress that assess the effect of tropomodulin overexpression and elimination on cardiac myofibrillar organization are providing valuable information that confirms the effect of this protein on the length as well as stability of sarcomeric actin filaments (M.A.S., unpublished data). Although it is clear that tropomodulin can affect tropomyosin binding to actin10 and, in turn, tropomyosin affects actin filament stability,35-37 it still is not clear how tropomodulin will stabilize and cap the end of the actin filament. Thin filaments are capped in vivo, since actin polymerization cannot be initiated on native thin filaments. 38 The experiments presented in this report indicate that tropomodulin protein is organized into myofibrils without localized mRNA translation, indicating that tropomodulin exerts influence by protein-protein interaction within very selective regions of myofibrils. The conservation of the tropomodulin-to-actin filament ratio between skeletal muscle and erythrocytes9 as well as the dramatic effects of disrupting normal stoichiometric ratios on myofibril organization (M.A.S., unpublished data) suggests that the protein responsible for controlling actin filament length and/or stability from the pointed end has indeed been isolated. Definitive experiments to confirm tropomodulin's regulatory role in thin filament organization are under way, with implications for all the various tissues where this protein has been identified.
